Home About us Articles Multimedia Search Instructions Login 
5 years IF: 1.036 (® Thomson Reuters)
IF 2016: 1.064 (® Thomson Reuters)
Total Cites: 7140
Follow Us
Follow Us
  • Users Online: 2571
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naÏve Patients Infected with Genotype 1b Hepatitis C Virus

Wang Ye, Rao Hui-Ying, Xie Xing-Wang, Wei Lai

Year : 2015| Volume: 128| Issue : 19 | Page no: 2625-2631

   This article has been cited by
1 Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C
Elif Sargin Altunok,Murat Sayan,Sila Akhan,Bilgehan Aygen,Orhan Yildiz,Suda Tekin Koruk,Resit Mistik,Nese Demirturk,Onur Ural,Sükran Kose,Aynur Aynioglu,Fatime Korkmaz,Gülden Ersoz,Nazan Tuna,Celal Ayaz,Faruk Karakecili,Derya Keten,Dilara Inan,Saadet Yazici,Safiye Koculu,Taner Yildirmak
International Journal of Infectious Diseases. 2016; 50: 1
[Pubmed]  [Google Scholar] [DOI]
2 Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals
Nicola Coppola,Carmine Minichini,Mario Starace,Caterina Sagnelli,Evangelista Sagnelli
Journal of Medical Virology. 2016; 88(10): 1659
[Pubmed]  [Google Scholar] [DOI]
3 miRNA antagonism and direct-acting antivirals: could this be a novel combination treatment against HCV?
Lingyao Du,Hong Tang
Future Virology. 2016; 11(12): 753
[Pubmed]  [Google Scholar] [DOI]
4 Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naďve HIV/HCV Co-Infected Patients in China
Kali Zhou,Zhiwei Liang,Charles Wang,Fengyu Hu,Chuanyi Ning,Yun Lan,Xiaoping Tang,Joseph D. Tucker,Weiping Cai,Luis Menéndez-Arias
PLOS ONE. 2016; 11(6): e0157438
[Pubmed]  [Google Scholar] [DOI]


Read this article